Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Sales | 1,011,500 | 1,243,400 | 1,295,500 | 1,459,600 | 429,900 |
| Cost of Goods | 141,400 | 250,600 | 256,900 | 329,500 | -98,800 |
| Gross Profit | 870,100 | 992,800 | 1,038,600 | 1,130,100 | 528,700 |
| Operating Expenses | 579,400 | 627,500 | 776,000 | 742,200 | 330,200 |
| Operating Income | 291,100 | 365,900 | 263,500 | 388,400 | 197,700 |
| Other Income | 20,000 | 21,700 | 11,600 | 10,200 | 13,700 |
| Pre-tax Income | 311,100 | 387,600 | 275,100 | 398,600 | 211,400 |
| Income Tax | 20,700 | 52,700 | 20,900 | 58,100 | 10,900 |
| Net Income Continuous | 290,400 | 334,900 | 254,200 | 340,500 | 200,500 |
| Net Income Discontinuous | 79,300 | 48,800 | 51,300 | N/A | N/A |
| Minority Interests | -200 | -1,200 | -1,600 | N/A | N/A |
| Net Income | $369,900 | $384,900 | $307,100 | $340,500 | $398,400 |
| EPS Basic Total Ops | 0.61 | 0.63 | 0.51 | 0.56 | 0.66 |
| EPS Basic Continuous Ops | 0.49 | 0.55 | 0.42 | 0.56 | 0.33 |
| EPS Basic Discontinuous Ops | 0.12 | 0.08 | 0.09 | N/A | N/A |
| EPS Diluted Total Ops | 0.61 | 0.63 | 0.50 | 0.56 | 0.65 |
| EPS Diluted Continuous Ops | 0.48 | 0.55 | 0.42 | 0.56 | 0.33 |
| EPS Diluted Discontinuous Ops | 0.13 | 0.08 | 0.08 | N/A | N/A |
| EBITDA(a) | $327,800 | $402,800 | $299,600 | $423,600 | $233,100 |